|
⚲
|
| Keyboard |
| Oncobiomix Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001998501 |
| Sale | 2026-09-14 (2.5 M Offered, 0.1 M Sold) |
| Fund | |
| Phone | 2103056513 |
| Address | 3463 Magic Drive San Antonio, TX 78229 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-16 (D) |
| Exemption | 506(b) |
| Remaining | $2,400,000 |
| Duration | More than one year |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Michael Liss | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Center Coast Capital Advisors LP
✚
|
TX | |
|
Nexbank Securities Inc
✚
|
TX | |
|
Chessman Wealth Strategies Inc
✚
|
TX | |
|
Green Future Partners LLC
✚
|
TX | |
|
Deloache Capital Fund Manager LLC
✚
|
TX | |
|
SailingStone Capital Partners LLC
✚
|
TX | |
|
N2 Capital Management LP
✚
|
TX | |
|
Highside Capital Management LP
✚
|
TX | |
|
Main Street Capital Corporation
✚
|
TX | |
|
Energent LP
✚
|
TX |